Search
-
Lucy Ellis
https://le.ac.uk/about/history/obituaries/2023/lucy-ellis
It is with great sadness that we share news of the death of Lucy Ellis, our colleague in Library and Learning Services. Lucy was taken ill earlier this year and had been receiving ongoing treatment.
-
Andrew Dunn: Page 77
https://staffblogs.le.ac.uk/socscilibrarians/author/andrew_dunn/page/77/
Academic Librarian.
-
Andrew Dunn: Page 136
https://staffblogs.le.ac.uk/socscilibrarians/author/andrew_dunn/page/136/
Academic Librarian.
-
Social Sciences and Humanities Librarians’ Blog: Academic and staff blogs from the University of Lei
https://staffblogs.le.ac.uk/socscilibrarians/page/77/
Academic and staff blogs from the University of Leicester
-
Social Sciences and Humanities Librarians’ Blog: Academic and staff blogs from the University of Lei
https://staffblogs.le.ac.uk/socscilibrarians/page/181/
Academic and staff blogs from the University of Leicester
-
Andrew Dunn: Page 180
https://staffblogs.le.ac.uk/socscilibrarians/author/andrew_dunn/page/180/
Academic Librarian.
-
Opportunities open up in South Korea for students and researchers
https://le.ac.uk/news/2015/november/opportunities-open-up-in-south-korea-for-students-and-researchers
We have signed a new agreement with a major university in South Korea to send students to South East Asia as part of their degree programme.
-
Instruments
https://le.ac.uk/cbs/facilities/flow-cytometry/instruments
Get more information on the instruments and equipment available as part of the Flow Cytometry facility at Leicester.
-
David Critchley
https://le.ac.uk/people/david-critchley
The academic profile of Professor David Critchley, Emeritus Professor of Molecular Cell Biology at University of Leicester
-
Leicester spinout technology hailed as most commercially viable
https://le.ac.uk/news/2015/september/leicester-spin-out-technology-hailed-as-2018most-commercially-viable2019
A technology developed at the University, and the prime focus of Leicester spin-out company MIP Diagnostics, has been recognised as ‘most commercially viable’ at Europe’s flagship Drug Discovery event.